Compounds > carbidopa

carbidopa and Lung Neoplasms

carbidopa has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ames, MM; Frederick, LM; Gilbert, JA; Pobst, LJ1
Ames, MM; Frederick, LM; Gilbert, JA1

Other Studies

2 other study(ies) available for carbidopa and Lung Neoplasms

ArticleYear
Hydrogen peroxide degradation and selective carbidopa-induced cytotoxicity against human tumor lines.
    Biochemical pharmacology, 2005, Apr-15, Volume: 69, Issue:8

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Carcinoid Tumor; Carcinoma, Small Cell; Cell Survival; Culture Media; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Kinetics; Lung Neoplasms; Oxidation-Reduction; Pyruvic Acid; Tumor Cells, Cultured

2005
The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:11

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Carcinoid Tumor; Carcinoma, Small Cell; Cell Division; Enzyme Inhibitors; Humans; Ileum; Liver; Lung Neoplasms; Microscopy, Electron; Tumor Cells, Cultured

2000